Cost effectiveness of autologous blood donation

Margot S. Kruskall, Arturo Pereira, Avery Comarow, David Lubarsky, Jeff Etchason, Steven Kleinman, Harold S. Kaplan, Cynthia Rutherford

Research output: Contribution to journalLetter

7 Citations (Scopus)

Abstract

To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.

Original languageEnglish (US)
Pages (from-to)461-463
Number of pages3
JournalNew England Journal of Medicine
Volume333
Issue number7
DOIs
StatePublished - Aug 17 1995
Externally publishedYes

Fingerprint

Blood Donors
Blood Transfusion
Cost-Benefit Analysis
Hepatitis Viruses
Aptitude
Virus Diseases
Hepatitis C
Hepatitis B
Communication
Tissue Donors
HIV
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kruskall, M. S., Pereira, A., Comarow, A., Lubarsky, D., Etchason, J., Kleinman, S., ... Rutherford, C. (1995). Cost effectiveness of autologous blood donation. New England Journal of Medicine, 333(7), 461-463. https://doi.org/10.1056/NEJM199508173330717

Cost effectiveness of autologous blood donation. / Kruskall, Margot S.; Pereira, Arturo; Comarow, Avery; Lubarsky, David; Etchason, Jeff; Kleinman, Steven; Kaplan, Harold S.; Rutherford, Cynthia.

In: New England Journal of Medicine, Vol. 333, No. 7, 17.08.1995, p. 461-463.

Research output: Contribution to journalLetter

Kruskall, MS, Pereira, A, Comarow, A, Lubarsky, D, Etchason, J, Kleinman, S, Kaplan, HS & Rutherford, C 1995, 'Cost effectiveness of autologous blood donation', New England Journal of Medicine, vol. 333, no. 7, pp. 461-463. https://doi.org/10.1056/NEJM199508173330717
Kruskall MS, Pereira A, Comarow A, Lubarsky D, Etchason J, Kleinman S et al. Cost effectiveness of autologous blood donation. New England Journal of Medicine. 1995 Aug 17;333(7):461-463. https://doi.org/10.1056/NEJM199508173330717
Kruskall, Margot S. ; Pereira, Arturo ; Comarow, Avery ; Lubarsky, David ; Etchason, Jeff ; Kleinman, Steven ; Kaplan, Harold S. ; Rutherford, Cynthia. / Cost effectiveness of autologous blood donation. In: New England Journal of Medicine. 1995 ; Vol. 333, No. 7. pp. 461-463.
@article{da75d38c77bf4adfad41df59f50adda9,
title = "Cost effectiveness of autologous blood donation",
abstract = "To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.",
author = "Kruskall, {Margot S.} and Arturo Pereira and Avery Comarow and David Lubarsky and Jeff Etchason and Steven Kleinman and Kaplan, {Harold S.} and Cynthia Rutherford",
year = "1995",
month = "8",
day = "17",
doi = "10.1056/NEJM199508173330717",
language = "English (US)",
volume = "333",
pages = "461--463",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "7",

}

TY - JOUR

T1 - Cost effectiveness of autologous blood donation

AU - Kruskall, Margot S.

AU - Pereira, Arturo

AU - Comarow, Avery

AU - Lubarsky, David

AU - Etchason, Jeff

AU - Kleinman, Steven

AU - Kaplan, Harold S.

AU - Rutherford, Cynthia

PY - 1995/8/17

Y1 - 1995/8/17

N2 - To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.

AB - To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.

UR - http://www.scopus.com/inward/record.url?scp=0029148832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029148832&partnerID=8YFLogxK

U2 - 10.1056/NEJM199508173330717

DO - 10.1056/NEJM199508173330717

M3 - Letter

C2 - 7617008

AN - SCOPUS:0029148832

VL - 333

SP - 461

EP - 463

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 7

ER -